BML Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

BML Pharmaceuticals Ownership

Who owns BML Pharmaceuticals?

BML Pharmaceuticals is owned by Endo International. It was acquired on July 29, 2002.

BML Pharmaceuticals Business Overview

Where is BML Pharmaceuticals headquartered?

BML Pharmaceuticals is headquartered in Manhasset, New York.

What sector is BML Pharmaceuticals in?

BML Pharmaceuticals is a life science company.

When was BML Pharmaceuticals founded?

BML Pharmaceuticals was founded in 1996.

Life Science M&A Summary in 2002

Out of 60 sectors in the Mergr database, life science ranked 12 in number of deals in 2002. The largest life science acquisition in 2002 was Immunex - which was acquired by Amgen for $16.0B.

Join Mergr to view all 36 acquisitions of life science companies in 2002, including 11 acquisitions by private equity firms, and 25 by strategics.

BML Pharmaceuticals

BML Pharmaceuticals, Inc.

1129 Northern Boulevard, Suite 406,
Manhasset, New York 11030
United States,
(516)869-5801

BML Pharmaceuticals is a provider of researches, develops, and manufactures a range of proprietary prescriptive and OTC pharmaceutical products. BML Pharmaceuticals was founded in 1996 and is based in Manhasset, New York.


 Subscribe to unlock this and 201,888
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.